Home > Screening Libraries > Clinical Compound Library

Clinical Compound Library

Catalog No. L3400

Clinical compound library is a collection of 1336 compounds, all of which have been permitted into the clinical trial phases. These compounds have known biological activities, low toxicity, and clear mechanism with demonstrated pre-clinical evidence.

Every compound contains detailed information on pharmacological activities, targets, clinical development status, and indications with broad spectrum covering several therapeutic areas from cancer, inflammation, infection, neuropsychiatry to cardiology, and many drug targets such as JAK, EGFR, mTOR, CDK, HDAC, AKT, PARP, etc. It is an effective tool for drug screening as well as for cell differentiation induction.

Pack Size	Price
100 μL * 10 mM (in DMSO)	USD 15850.00
250 μL * 10 mM (in DMSO)	USD 26070.00
1 mg	USD 26070.00

Product Description

A unique collection of 1336 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);
All compounds have been permitted into clinical trial phases, categorized into Phase 1, Phase 2 and Phase 3.
An effective tool for new drug screening and cell differentiation induction;
Detailed compound information with structure, target, activity, IC50 value, and biological activity description;
Structurally diverse, medicinally active, and cell permeable;
NMR and HPLC validated to ensure high purity and quality;

The compound library can be highly customized. You can select compounds, quantities, format (dry/solid or DMSO), plate map, and concentration to meet your specific requirement. Please check our Compound Library Instructions for more information.

Packaging and Storage

Powder or pre-dissolved DMSO solutions in 96 well plate with optional 2D barcode
Shipped with dry ice.

Library Composition

Most Related Compound Categories